孤儿药法案》与罕见癌症：1983-2022 年肿瘤孤儿药指定及相关批准的回顾性分析

IF 0.8 4区医学 Q4 PHARMACOLOGY & PHARMACY

Expert Opinion on Orphan Drugs Pub Date : 2024-03-20 DOI:10.1080/21678707.2024.2333245

Abraham Viju Ipe, Lewis J. Fermaglich, Selma Kraft, Catherine Mease, Tran Le, Kathleen L. Miller

{"title":"孤儿药法案》与罕见癌症：1983-2022 年肿瘤孤儿药指定及相关批准的回顾性分析","authors":"Abraham Viju Ipe, Lewis J. Fermaglich, Selma Kraft, Catherine Mease, Tran Le, Kathleen L. Miller","doi":"10.1080/21678707.2024.2333245","DOIUrl":null,"url":null,"abstract":"Rare cancers account for approximately 1 in 8 of all cancers diagnosed in the United States (US) every year. Remarkable scientific advances in cancer research over the past 40 years, in addition to...","PeriodicalId":12118,"journal":{"name":"Expert Opinion on Orphan Drugs","volume":"44 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022\",\"authors\":\"Abraham Viju Ipe, Lewis J. Fermaglich, Selma Kraft, Catherine Mease, Tran Le, Kathleen L. Miller\",\"doi\":\"10.1080/21678707.2024.2333245\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rare cancers account for approximately 1 in 8 of all cancers diagnosed in the United States (US) every year. Remarkable scientific advances in cancer research over the past 40 years, in addition to...\",\"PeriodicalId\":12118,\"journal\":{\"name\":\"Expert Opinion on Orphan Drugs\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Opinion on Orphan Drugs\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/21678707.2024.2333245\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Orphan Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21678707.2024.2333245","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

在美国每年确诊的所有癌症中，罕见癌症约占八分之一。在过去的 40 年中，癌症研究取得了显著的科学进步，此外...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022

Rare cancers account for approximately 1 in 8 of all cancers diagnosed in the United States (US) every year. Remarkable scientific advances in cancer research over the past 40 years, in addition to...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Expert Opinion on Orphan Drugs PHARMACOLOGY & PHARMACY-

CiteScore

2.30

自引率

0.00%

发文量

期刊介绍： Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs.